Guideline for disinfection and sterilization of prion-contaminated medical instruments

Infection Control and Hospital Epidemiology

Volumn 31, Issue 2, 2010, Pages 107-117

  Rutala, William A ^a   Weber, David J ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCLAVE; CREUTZFELDT JAKOB DISEASE; CREUTZFELDT JAKOB DISEASE AGENT; DISEASE TRANSMISSION; DISINFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INSTRUMENT STERILIZATION; MEDICAL INSTRUMENTATION; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; VIRAL CONTAMINATION; VIRUS INACTIVATION; VIRUS TRANSMISSION;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; DISINFECTION; EQUIPMENT CONTAMINATION; HUMANS; PRION DISEASES; PRIONS; STERILIZATION; SURGICAL INSTRUMENTS;

EID: 75949105990     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/650197     Document Type: Review

References (117)

1. Centers for Disease Control and Prevention (CDC). Surveillance for Creutzfeldt-Jakob disease - United States. MMWR Morb Mortal Wkly Rep 1996;45:665-668.
2. Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994-2004.
3. Collins SJ, Lawson VA, Masters CL. Transmissible spongiform encephalopathies. Lancet 2004;363:51-61.
4. Belay ED, Sejvar JJ, Shieh W-J, et al. Variant Creutzfeldt-Jakob disease death, United States. Emerg Infect Dis 2005;11:1351-1354.
5. Centers for Disease Control and Prevention (CDC). Probable variant Creutzfeldt-Jakob disease in a U.S. resident - Florida, 2002. MMWR Morb Mortal Wkly Rep 2002;51:927-929.
6. National Creutzfeldt-Jakob Disease Surveillance Unit. Variant Creutzfeldt-Jakob Diseases Current Data, July 2009. Edinburgh, Scotland:University of Edinburgh; 2009.
7. Belay ED, Maddox RA, Williams ES, Miller MW, Gambetti P, Schonberger LB. Chronic wasting disease and potential transmission to humans. Emerg Infect Dis 2004;10:977-984.
8. Kong Q, Huang S, Zou W, et al. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 2005;25:7944-7949.
9. Centers for Disease Control and Prevention (CDC). Fatal degenerative neurologic illnesses in men who participated in wild game feasts - Wisconsin, 2002. MMWR Morb Mortal Wkly Rep 2003;52:125-127.
10. Mawhinney S, Pape WJ, Forster JE, Anderson CA, Bosque P, Miller MW. Human prion disease and relative risk associated with chronic wasting disease. Emerg Infect Dis 2006;12:1527-1535.
11. Brown P, Brandel J-P, Preese M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006;67:389-393.
12. World Health Organization (WHO). WHO infection control guidelines for transmissible spongiform encephalopathies. Geneva, Switzerland: WHO; 2000. Available at: http://www.who.int/csr/resources/publications/bse/ whocdscsraph2003.pdf. Accessed January 3, 2010.
13. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-1081.
14. Brown P. Environmental causes of human spongiform encephalopathy. In: Baker H, Ridley RM, eds. Methods in Molecular Medicine: Prion Diseases. Totowa, NJ: Humana Press; 1996:139-154.
15. Brown P, Gibbs CJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-529.
16. Rutala WA, Weber DJ. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 2001;32:1348-1356.
17. McDonnell G. Prion disease transmission: Can we apply standard precautions to prevent or reduce risks? J Perioper Pract 2008;18:298-304.
18. Tamai Y, Kojima H, Kitajima R, et al. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. N Engl J Med 1992;327:649.
19. Zanusso G, Ferrari S, Cardone F, et al. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;348:711-719.
20. Geertsma RE, van Asten JAAM. Sterilization of prions: requirements, complications, implications. Zentralbl Steril 1995;3:385-394.
21. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;1(8009):478-479.
22. Nevin S, McMenemey WH, Behrman S, Jones DP. Subacute spongiform encephalopathy - a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 1960;83:519-569.
23. Foncin J-F, Gaches J, Cathala F, Sherif E, LeBeau J. Transmission iatrogè ne interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains du cervelet. Rev Neurol (Paris) 1980;136:280.
24. Barash JA, Johnson BT, Gregorio DI. Is surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variations by control choice and exposure assessments. Infect Control Hosp Epidemiol 2008;29:212-218.
25. Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, et al. Ophthalmic surgery in prion diseases. Emerg Infect Dis 2007;13:162-164.
26. Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis 2002; 34:797-805.
27. Fichet G, Comoy C, Duval C, et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004;364:521-526.
28. Fichet G, Comoy E, Dehen C, et al. Investigations of a prion infectivity assay to evaluate methods of decontamination. J Microbiol Methods 2007;70:511-518.
29. Yan ZX, Stitz L, Heeg P, Roth K, Mauz P-S. Low-temperature inactivation of prion-protein on surgical steel surfaces with hydrogen peroxide gas plasma sterilization. Zentralbl Steril 2008;16:26-34.
30. Jackson GS, McKintosh E, Flechsig E, et al. An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 2005;86:869-878.
31. Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000;159:10-17.
32. Rogez-Kreuz C, Yousfi R, Soufflet C, et al. Inactivation of animal and human prions by hydrogen peroxide gas plasma sterilization. Infect Control Hosp Epidemiol 2009;30:769-777.
33. Yan Z, Stitz L, Heeg P, Pfaff E, Roth K. Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 2004;25:280-283.
34. Solassol J, Arlotto M, Lehmann S. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention, and scrapie-cell assay. J Hosp Infect 2004;57:156-161.
35. Rutala WA, Weber DJ. Management of equipment contaminated with Creutzfeldt-Jakob disease. In: Rutala WA, ed. Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare Facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2001:167-172.
36. Fichet G, Antloga K, Comoy E, Deslys JP, McDonnell G. Prion inactivation using a new gaseous hydrogen peroxide sterilization process. J Hosp Infect 2007;67:278-286.
37. Peretz D, Supattapone S, Giles K, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 2006;80:322-331.
38. Dickinson AG, Taylor DM. Resistance of scrapie agent to decontamination. N Engl J Med 1978;299:1413-1414.
39. Hartley EG. Action of disinfectants on experimental mouse scrapie. Nature 1967;213:1135.
40. Walker JT, Dickinson J, Sutton JM, Marsh PD, Raven NDH. Implications for Creutzfeldt-Jakob disease (CJD) in dentistry: a review of current knowledge. J Dent Res 2008;87:511-519.
41. Taylor DM, Fernie K, McConnell I. Inactivation of the 22A strain of scrapie agent by autoclaving in sodium hydroxide. Vet Microbiol 1997; 58:87-91.
42. Brown P, Rohwer RG, Green EM, Gajdusek DC. Effect of chemicals, heat, and histopathologic processing on high-infectivity hamsteradapted scrapie virus. J Infect Dis 1982;145:683-687.
43. Kimberlin RH, Walker CA, Millson GC, et al. Disinfection studies with two strains of mouse-passaged scrapie agent: guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci 1983;59:355-369.
44. Taylor DM, Fraser H, McConnell I, et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 1994;139:313-326.
45. Vadrot C, Darbord J-C. Quantitative evaluation of prion inactivation comparing steam sterilization and chemical sterilants: proposed method for test standardization. J Hosp Infect 2006;64:143-148.
46. Baxter HC, Campbell GA, Whittaker AG, et al. Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. J Gen Virol 2005;86:2393-2399.
47. Ernst DR, Race RE. Comparative analysis of scrapie agent inactivation methods. J Virol Methods 1993;41:193-201.
48. Sutton JM, Dickinson J, Walker JT, Raven NDH. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard? Clin Infect Dis 2006;43:757-764.
49. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 1999;5:240-243.
50. Taylor DM, Diprose MF. The response of the 22A strain of scrapie agent to microwave irradiation compared to boiling. Neuropathol Appl Neurobiol 1996;22:256-258.
51. Taylor DM, McConnell I. Autoclaving does not decontaminate formolfixed scrapie tissues. Lancet 1988;1(8600):1463-1464.
52. Taylor DM. Inactivation of prions by physical and chemical means. J Hosp Infect 1999;43 (Suppl):S69-S76.
53. Rutala WA; 1994, 1995, and 1996 APIC Guidelines Committee. APIC guideline for selection and use of disinfectants. Association for Professionals in Infection Control and Epidemiology. Am J Infect Control 1996; 24:313-342.
54. Rutala WA, Weber DJ. FDA labeling requirements for disinfection of endoscopes: a counterpoint. Infect Control Hosp Epidemiol 1995;16:231-235.
55. Merritt K, Hitchins VM, Brown SA. Safety and cleaning of medical materials and devices. J Biomed Mater Res 2000;53:131-136.
56. Alfa MJ, Jackson M. A new hydrogen peroxide-based medical-device detergent with germicidal properties: comparison with enzymatic cleaners. Am J Infect Control 2001;29:168-177.
57. Jacobs P. Cleaning: principles, methods and benefits. In: Rutala WA, ed. Disinfection, Sterilization, and Antisepsis in Healthcare. Champlain, NY: Polyscience Publications; 1998:165-181.
58. Stephenson J. Halting the spread of human prion disease - exceptional measures for an exceptional problem. J Hosp Infect 2007;65:14-18.
59. Lipscomb IP, Pinchin H, Collin R, Kevil CW. Effect of drying time, ambient temperature and pre-soaks on prion-infected tissue contamination levels on surgical stainless steel: concerns over prolonged transportation of instruments from theatre to central sterile service departments. J Hosp Infect 2007;65:72-77.
60. Baier M, Schwarz A, Mielke M. Activity of an alkaline 'cleaner' in the inactivation of the scrapie agent. J Hosp Infect 2004;57:80-84.
61. Yoshioka M, Murayama Y, Miwa T, et al. Assessment of prion inactivation by combined use of Bacillus-derived protease and SDS. Biosci Biotechnol Biochem 2007;71:2565-2568.
62. Lawson VA, Stewart JD, Masters CL. Enzymatic detergent treatment protocol that reduces protease-resistant prion load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. J Gen Virol 2007;88:2905-2914.
63. United Kingdom Department of Health. New technologies working group report on prion inactivating agents. London, UK: Department of Health; 2008:1-30.
64. Fichet G, Harrison J, McDonnell G. Reduction of risk of prion transmission on surgical devices with effective cleaning processes. Zentralbl Steril 2007;15:418-437.
65. McLeod AH, Murdoch H, Dickinson J, et al. Proteolytic inactivation of the bovine spongiform encephalopathy agent. Biochem Biophys Res Commun 2004;317:1165-1170.
66. McDonnell G, Fichet G, Kaiser H, et al. Cleaning investigations to reduce the risk of prion contamination on manufacturing surfaces and materials. Eur J Parenter Pharm Sci 2005;10:67-72.
67. Dickinson J, Murdoch H, Dennis MJ, et al. Decontamination of prion protein (BSE301V) using a genetically engineered protease. J Hosp Infect 2009;72:65-70.
68. Rohwer RG. Virus like sensitivity of the scrapie agent to heat inactivation. Science 1984;223:600-602.
69. Fernie K, Steele PJ, Taylor DM, Somerville RA. Comparative studies on the thermostability of five strains of transmissible-spongiform-encephalopathy agent. Biotechnol Appl Biochem 2007;47:175-183.
70. Murdoch H, Taylor D, Dickinson J, et al. Surface decontamination of surgical instruments: an ongoing dilemma. J Hosp Infect 2006;63:432-438.
71. Sattar SA, Springthorpe VS. New methods for efficacy testing of disinfectants and antiseptics. In: Rutala WA, ed. Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare Facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2001:174-186.
72. McDonnell G, Amato R, Malchesky PS, Muzic DS, Marchant RE. Use of Dacron as an alternative for evaluating oxidizing sterilants in the AOAC sporicidal tests. J AOAC Int 2000;83:269-275.
73. Ascenzi JM, Ezzell RJ, Wendt TM. A more accurate method for measurement of tuberculocidal activity of disinfectants. Appl Environ Microbiol 1987;53:2189-2192.
74. Rutala WA, Cole EC. Ineffectiveness of hospital disinfectants against bacteria: a collaborative study. Infect Control 1987;8:501-506.
75. Cole EC, Rutala WA, Alfano EM. Comparison of stainless steel penicylinders used in disinfectant testing. J Assoc Off Anal Chem 1988;71: 288-289.
76. Cole EC, Rutala WA, Nessen L, Wannamaker NS, Weber DJ. Effect of methodology, dilution, and exposure time on the tuberculocidal activity of glutaraldehyde-based disinfectants. Appl Environ Microbiol 1990;56: 1813-1817.
77. Steelman VM. Activity of sterilization processes and disinfectants against prions (Creutzfeldt-Jakob disease agent). In: Rutala WA, ed. Disinfection, Sterilization, and Antisepsis in Healthcare. Champlain, NY: Polyscience Publications; 1998:255-271.
78. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001;7: 679-684.
79. sc bound to steel surfaces. J Gen Virol 2004;85:3805-3816.
80. Langeveld JPM, Wang JJ, Van de Wiel DFM, Shih GC, et al. Enzymatic degradation of prion protein in brain stem from infected cattle and sheep. J Infect Dis 2003;188:1782-1789.
81. Race RE, Raymond GJ. Inactivation of transmissible spongiform encephalopathy (prion) agents by Environ LpH. J Virol 2004;78:2164-2165.
82. Riemer C, Bamme T, Mok SWF, Baier M. 3-methyl-4-chlorophenol for prion decontamination of medical devices. Infect Control Hosp Epidemiol 2006;27:778-780.
83. Brown P, Rohwer RG, Gajdusek DC. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 1986;153:1145-1148.
84. Brown P, Gibbs CJ Jr, Amyx HL, et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 1982;306:1279-1282.
85. Solassol J, Pastore M, Crozet C, Perrier V, Lehmann S. A novel copperhydrogen peroxide formulation for prion decontamination. J Infect Dis 2006;194:865-869.
86. Manuelidis L. Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J Neurovirol 1997;3:62-65.
87. Tateishi J, Tashima T, Kitamoto T. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol Immunol 1991;35:163-166.
88. Taylor DM. Resistance of the ME7 scrapie agent to peracetic acid. Vet Microbiol 1991;27:19-24.
89. Taguchi F, Tamai Y, Uchida A, et al. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Arch Virol 1991;119:297-301.
90. Brown SA, Merritt K. Use of containment pans and lids for autoclaving caustic solutions. Am J Infect Control 2003;31:257-260.
91. Rabano A, de Pedro-Cuesta J, Molbak K, et al. Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease: a proposal on hypothetical risk levels. BMC Public Health 2005;5:9.
92. Favero MS. Current issues in hospital hygiene and sterilization technology. J Infect Control (Asia Pacific Ed.) 1998;1:8-10.
93. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, Sterilization, and Preservation. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:881-917.
94. Committee on Health Care Issues, American Neurological Association. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Ann Neurol 1986;19:75-77.
95. Association of periOperative Registered Nurses (AORN). Recommended practices for cleaning and caring for surgical instruments and powered equipment. In: AORN, ed. Standards, Recommended Practices, and Guidelines. Denver: AORN; 2006:555-563.
96. Association for the Advancement of Medical Instrumentation (AAMI). Comprehensive guide to steam sterilization and sterility assurance in health care facilities. Arlington, VA: AAMI; 2006:ANSI/AAMI ST79.
97. Kampf G, Blob R, Martiny H. Surface fixation of dried blood by glutaraldehyde and peracetic acid. J Hosp Infect 2004;57:139-143.
98. Brown P, Liberski PP, Wolff A, et al. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360°C: practical and theoretical implications. J Infect Dis 1990; 161:467-472.
99. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990;40:887-890.
100. CLSI. Protection of laboratory workers from occupationally acquired infections; approved guideline - third edition. CLSI document. Wayne, PA: CLSI; 2005:M29-A3.
101. Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008. Atlanta, GA: CDC. Published November 2008. http://cdc.gov/ncidod/dhqp/pdf/guidelines/Disinfection-Nov-2008.pdf. Accessed January 3, 2010.
102. Rutala WA, Weber DJ. How to assess disease transmission when there is a failure to follow recommended disinfection and sterilization principles. Infect Control Hosp Epidemiol 2007;28:519-524.
103. Bourvis N, Boelle P-Y, Cesbron J-Y, Valleron A-J. Risk assessment of transmission of sporadic Creutzfeldt-Jakob disease in endodontic practice in absence of adequate prion inactivation. PLoS One 2007;2(12):e1330.
104. Stricof RL, Lillquist PP, Thomas N, Belay ED, Schonberger LB, Morse DL. An investigation of potential neurosurgical transmission of Creutzfeldt-Jakob disease: challenges and lessons learned. Infect Control Hosp Epidemiol 2006;27:302-304.
105. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-529.
106. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363: 417-421.
107. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368:2061-2067.
108. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveill 2007;12(1):E070118.4.
109. Azarpazhooh A, Fillery ED. Prion disease: the implications for dentistry. J Endod 2008;34:1158-1166.
110. Tullo A, Buckley R, Painter M. CJD and the eye. Eye (Lond) 2000;14: 259-260.
111. Kirkpatrick WNA, Waterhouse N. Pharyngoplasty and the risk of variant CJD transmission. Br J Plast Surg 2001;54:552-561.
112. Maheshwar A, De M, Browning ST. Reusable versus disposable instruments in tonsillectomy: a comparative study of outcomes. Int J Clin Pract 2003;57:579-583.
113. Weber DJ, Rutala WA. Managing the risk of nosocomial transmission of prion diseases. Curr Opin Infect Dis 2002;15:421-425.
114. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; final rule. Fed Regist 1991;56:64003-64182.
115. Tyler KL. Prions and prion diseases of the central nervous system(transmissible neurodegenerative diseases). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practices of Infectious Diseases. Philadelphia: Churchill Livingstone; 2000:1971-1985.
116. Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis 2001;7:6-16. (Pubitemid 32173328)
117. Association for peri-Operative Registered Nurses (AORN). Recommended practices for sterilization in the perioperative practice setting. In: AORN, ed. Standards, Recommended Practices, and Guidelines. Denver: AORN; 2006:629-643.